Logo image of BLBD

BLUE BIRD CORP (BLBD) Stock Fundamental Analysis

NASDAQ:BLBD - Nasdaq - US0953061068 - Common Stock - Currency: USD

44.98  -0.62 (-1.36%)

After market: 44.98 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to BLBD. BLBD was compared to 128 industry peers in the Machinery industry. Both the profitability and the financial health of BLBD get a neutral evaluation. Nothing too spectacular is happening here. BLBD scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, BLBD could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BLBD had positive earnings in the past year.
In the past year BLBD had a positive cash flow from operations.
In multiple years BLBD reported negative net income over the last 5 years.
In multiple years BLBD reported negative operating cash flow during the last 5 years.
BLBD Yearly Net Income VS EBIT VS OCF VS FCFBLBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

BLBD has a Return On Assets of 19.89%. This is amongst the best in the industry. BLBD outperforms 99.22% of its industry peers.
With an excellent Return On Equity value of 56.80%, BLBD belongs to the best of the industry, outperforming 97.66% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 28.98%, BLBD belongs to the top of the industry, outperforming 98.44% of the companies in the same industry.
Industry RankSector Rank
ROA 19.89%
ROE 56.8%
ROIC 28.98%
ROA(3y)4.43%
ROA(5y)3.41%
ROE(3y)-1048.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLBD Yearly ROA, ROE, ROICBLBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

BLBD's Profit Margin of 7.97% is fine compared to the rest of the industry. BLBD outperforms 61.72% of its industry peers.
In the last couple of years the Profit Margin of BLBD has grown nicely.
BLBD has a Operating Margin (9.74%) which is in line with its industry peers.
BLBD's Operating Margin has improved in the last couple of years.
The Gross Margin of BLBD (19.18%) is worse than 75.00% of its industry peers.
In the last couple of years the Gross Margin of BLBD has grown nicely.
Industry RankSector Rank
OM 9.74%
PM (TTM) 7.97%
GM 19.18%
OM growth 3Y121.61%
OM growth 5Y19.19%
PM growth 3YN/A
PM growth 5Y26.86%
GM growth 3Y21.73%
GM growth 5Y7.73%
BLBD Yearly Profit, Operating, Gross MarginsBLBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BLBD is creating value.
The number of shares outstanding for BLBD has been increased compared to 1 year ago.
BLBD has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BLBD has been reduced compared to a year ago.
BLBD Yearly Shares OutstandingBLBD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BLBD Yearly Total Debt VS Total AssetsBLBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 6.00 indicates that BLBD is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 6.00, BLBD belongs to the best of the industry, outperforming 82.03% of the companies in the same industry.
BLBD has a debt to FCF ratio of 1.07. This is a very positive value and a sign of high solvency as it would only need 1.07 years to pay back of all of its debts.
BLBD's Debt to FCF ratio of 1.07 is amongst the best of the industry. BLBD outperforms 85.16% of its industry peers.
BLBD has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of BLBD (0.46) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 1.07
Altman-Z 6
ROIC/WACC2.92
WACC9.91%
BLBD Yearly LT Debt VS Equity VS FCFBLBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

BLBD has a Current Ratio of 1.45. This is a normal value and indicates that BLBD is financially healthy and should not expect problems in meeting its short term obligations.
BLBD has a Current ratio of 1.45. This is in the lower half of the industry: BLBD underperforms 78.13% of its industry peers.
A Quick Ratio of 0.73 indicates that BLBD may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.73, BLBD is doing worse than 82.81% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 0.73
BLBD Yearly Current Assets VS Current LiabilitesBLBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.76% over the past year.
Measured over the past years, BLBD shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.38% on average per year.
The Revenue has been growing slightly by 7.57% in the past year.
BLBD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.74% yearly.
EPS 1Y (TTM)22.76%
EPS 3Y123.91%
EPS 5Y16.38%
EPS Q2Q%7.87%
Revenue 1Y (TTM)7.57%
Revenue growth 3Y25.35%
Revenue growth 5Y5.74%
Sales Q2Q%3.74%

3.2 Future

BLBD is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.83% yearly.
The Revenue is expected to grow by 6.99% on average over the next years.
EPS Next Y11.4%
EPS Next 2Y10.42%
EPS Next 3Y6.83%
EPS Next 5YN/A
Revenue Next Year9.16%
Revenue Next 2Y8.58%
Revenue Next 3Y5.57%
Revenue Next 5Y6.99%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BLBD Yearly Revenue VS EstimatesBLBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
BLBD Yearly EPS VS EstimatesBLBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3 4

7

4. Valuation

4.1 Price/Earnings Ratio

BLBD is valuated correctly with a Price/Earnings ratio of 12.63.
BLBD's Price/Earnings ratio is rather cheap when compared to the industry. BLBD is cheaper than 88.28% of the companies in the same industry.
When comparing the Price/Earnings ratio of BLBD to the average of the S&P500 Index (27.29), we can say BLBD is valued rather cheaply.
BLBD is valuated reasonably with a Price/Forward Earnings ratio of 10.60.
Based on the Price/Forward Earnings ratio, BLBD is valued cheaply inside the industry as 90.63% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of BLBD to the average of the S&P500 Index (21.74), we can say BLBD is valued rather cheaply.
Industry RankSector Rank
PE 12.63
Fwd PE 10.6
BLBD Price Earnings VS Forward Price EarningsBLBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BLBD is valued cheaply inside the industry as 80.47% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, BLBD is valued a bit cheaper than the industry average as 73.44% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 16.27
EV/EBITDA 9.38
BLBD Per share dataBLBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BLBD has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.11
PEG (5Y)0.77
EPS Next 2Y10.42%
EPS Next 3Y6.83%

0

5. Dividend

5.1 Amount

No dividends for BLBD!.
Industry RankSector Rank
Dividend Yield N/A

BLUE BIRD CORP

NASDAQ:BLBD (7/7/2025, 8:01:18 PM)

After market: 44.98 0 (0%)

44.98

-0.62 (-1.36%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners118.16%
Inst Owner Change0%
Ins Owners0.58%
Ins Owner Change1.73%
Market Cap1.42B
Analysts83.08
Price Target52.6 (16.94%)
Short Float %16.5%
Short Ratio12.77
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.87%
Min EPS beat(2)-0.8%
Max EPS beat(2)10.53%
EPS beat(4)3
Avg EPS beat(4)24.77%
Min EPS beat(4)-0.8%
Max EPS beat(4)74.11%
EPS beat(8)7
Avg EPS beat(8)53.29%
EPS beat(12)9
Avg EPS beat(12)-95.09%
EPS beat(16)10
Avg EPS beat(16)-86.39%
Revenue beat(2)0
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-0.95%
Max Revenue beat(2)-0.19%
Revenue beat(4)1
Avg Revenue beat(4)0.55%
Min Revenue beat(4)-0.95%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)4.08%
Revenue beat(12)8
Avg Revenue beat(12)5.72%
Revenue beat(16)10
Avg Revenue beat(16)4.68%
PT rev (1m)-2.7%
PT rev (3m)-2.7%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.69%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.65%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.75%
Valuation
Industry RankSector Rank
PE 12.63
Fwd PE 10.6
P/S 1.05
P/FCF 16.27
P/OCF 12.85
P/B 7.46
P/tB 11.01
EV/EBITDA 9.38
EPS(TTM)3.56
EY7.91%
EPS(NY)4.24
Fwd EY9.43%
FCF(TTM)2.76
FCFY6.15%
OCF(TTM)3.5
OCFY7.78%
SpS42.96
BVpS6.03
TBVpS4.08
PEG (NY)1.11
PEG (5Y)0.77
Profitability
Industry RankSector Rank
ROA 19.89%
ROE 56.8%
ROCE 41.65%
ROIC 28.98%
ROICexc 49.31%
ROICexgc 73.58%
OM 9.74%
PM (TTM) 7.97%
GM 19.18%
FCFM 6.44%
ROA(3y)4.43%
ROA(5y)3.41%
ROE(3y)-1048.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y220.13%
ROICexcg growth 5Y10.5%
ROICexc growth 3Y207.87%
ROICexc growth 5Y19.73%
OM growth 3Y121.61%
OM growth 5Y19.19%
PM growth 3YN/A
PM growth 5Y26.86%
GM growth 3Y21.73%
GM growth 5Y7.73%
F-Score8
Asset Turnover2.49
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 1.07
Debt/EBITDA 0.59
Cap/Depr 152.12%
Cap/Sales 1.71%
Interest Coverage 12.82
Cash Conversion 75.01%
Profit Quality 80.71%
Current Ratio 1.45
Quick Ratio 0.73
Altman-Z 6
F-Score8
WACC9.91%
ROIC/WACC2.92
Cap/Depr(3y)67.41%
Cap/Depr(5y)84.95%
Cap/Sales(3y)0.9%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.76%
EPS 3Y123.91%
EPS 5Y16.38%
EPS Q2Q%7.87%
EPS Next Y11.4%
EPS Next 2Y10.42%
EPS Next 3Y6.83%
EPS Next 5YN/A
Revenue 1Y (TTM)7.57%
Revenue growth 3Y25.35%
Revenue growth 5Y5.74%
Sales Q2Q%3.74%
Revenue Next Year9.16%
Revenue Next 2Y8.58%
Revenue Next 3Y5.57%
Revenue Next 5Y6.99%
EBIT growth 1Y7.72%
EBIT growth 3Y177.79%
EBIT growth 5Y26.04%
EBIT Next Year39.1%
EBIT Next 3Y15.18%
EBIT Next 5Y14.15%
FCF growth 1Y249.42%
FCF growth 3YN/A
FCF growth 5Y36.54%
OCF growth 1Y248.76%
OCF growth 3YN/A
OCF growth 5Y14.81%